United States of America
Diabetes country report 2000 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in United States of America (US)
| 2000 | 15.3 million |
| 2011 | 23.7 million |
| 2024 | 38.5 million |
| 2050 | 43.0 million |
USA is one of the 22 countries and territories in the IDF North America and Caribbean Region. USA has the third highest number of adults (20-79 years) with diabetes in the world and the highest total diabetes-related health expenditure.
Data source(s) used for the diabetes estimates in adults:
- Andy Menke et al. JAMA. 2015;314(10):1021-1029. doi:10.1001/jama.2015.10029. PMID:26348752.
- US Centers for disease control and prevention. National Health and Nutrition Examination Survey, NHANES 2017-2020
2000
2011
2024
2050
Loading...
| Diabetes estimates (20-79 y) | ||||
|---|---|---|---|---|
| People with diabetes, in 1,000s | 15,280.0 | 23,721.8 | 38,536.4 | 43,025.3 |
| Age-standardised prevalence of diabetes, % | - | 9.4 | 13.7 | 15.2 |
| Proportion of people with undiagnosed diabetes, % | - | - | 24.8 | - |
| People with undiagnosed diabetes, in 1,000s | - | - | 9,557.0 | - |
| Impaired Fasting Glucose (IFG) | ||||
|---|---|---|---|---|
| People with IFG, in 1,000s | - | - | 37,250.9 | 40,866.2 |
| Age-standardised prevalence of IFG, % | - | - | 14.2 | 14.9 |
| Impaired Glucose Tolerance (IGT) | ||||
|---|---|---|---|---|
| People with IGT, in 1,000s | - | 25,948.7 | 31,477.4 | 34,748.3 |
| Age-standardised prevalence of IGT, % | - | 10.6 | 11.5 | 12.5 |
| Mortality attributable to diabetes (20-79 y) | ||||
|---|---|---|---|---|
| Deaths attributable to diabetes | - | 179,612.0 | 363,427.0 | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 21.9 | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
|---|---|---|---|---|
| Live births affected by HIP | - | - | 986,048.3 | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | 21.4 | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | 56,674.1 | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | 171,850.6 | - |
| Diabetes-related health expenditure | ||||
|---|---|---|---|---|
| Total diabetes-related health expenditure, USD million | - | - | 404,531.0 | 407,209.0 |
| Total diabetes-related health expenditure, ID million | - | - | 404,531.0 | 407,209.0 |
| Diabetes-related health expenditure per person, USD | - | 8,468.0 | 10,497.4 | 9,464.4 |
| Diabetes-related health expenditure per person, ID | - | - | 10,497.4 | 9,464.4 |
| Type 1 diabetes estimates in children and adolescents | ||||
|---|---|---|---|---|
| People with type 1 diabetes (all age groups) | - | - | 1,476,859.0 | - |
| People with type 1 diabetes (0-19 y) | - | - | 196,778.3 | - |
| Demographics | ||||
|---|---|---|---|---|
| Total adult population (20-79 y), in 1,000s | 190,081.0 | 216,804.8 | 245,525.2 | 262,288.0 |
| Population of children and adolescents (0-19 y) | - | - | 82,611,598.0 | - |
Loading...
| Diabetes estimates (20-79 y) | |
|---|---|
| People with diabetes, in 1,000s | 15,280.0 |
| Age-standardised prevalence of diabetes, % | - |
| Proportion of people with undiagnosed diabetes, % | - |
| People with undiagnosed diabetes, in 1,000s | - |
| Impaired Fasting Glucose (IFG) | |
|---|---|
| People with IFG, in 1,000s | - |
| Age-standardised prevalence of IFG, % | - |
| Impaired Glucose Tolerance (IGT) | |
|---|---|
| People with IGT, in 1,000s | - |
| Age-standardised prevalence of IGT, % | - |
| Mortality attributable to diabetes (20-79 y) | |
|---|---|
| Deaths attributable to diabetes | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
|---|---|
| Live births affected by HIP | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - |
| Live births affected by other types of diabetes first detected in pregnancy | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - |
| Diabetes-related health expenditure | |
|---|---|
| Total diabetes-related health expenditure, USD million | - |
| Total diabetes-related health expenditure, ID million | - |
| Diabetes-related health expenditure per person, USD | - |
| Diabetes-related health expenditure per person, ID | - |
| Type 1 diabetes estimates in children and adolescents | |
|---|---|
| People with type 1 diabetes (all age groups) | - |
| People with type 1 diabetes (0-19 y) | - |
| Demographics | |
|---|---|
| Total adult population (20-79 y), in 1,000s | 190,081.0 |
| Population of children and adolescents (0-19 y) | - |
